The test is intended to help identify patients eligible for treatment with Sarepta Therapeutics’ ELEVIDYS gene therapy for individuals with Duchenne muscular dystrophy, according to an Aug. 30 news release.
Quest also announced its collaboration with Sarepta to develop other diagnostics to complement Sarepta’s gene therapies. It will also provide clinical lab testing for Sarepta.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
